Autoplaque vs V7 Diagnostic Ultrasound System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Autoplaque

by Cedars-Sinai Medical Center: AIM

V7 Diagnostic Ultrasound System

by Samsung Medison Co.

AI Verdict

Autoplaque is an AI-powered software for analyzing CT angiography images to quantify coronary plaques and luminal stenoses, aiding in heart attack risk prediction. The Samsung V7 is a versatile diagnostic ultrasound system with AI tools for various applications, including cardiovascular, women's health, and general imaging. While both offer AI-powered cardiovascular diagnostics, Autoplaque focuses specifically on CT-based plaque analysis, whereas the V7 is a broader ultrasound imaging system with a wider range of applications and imaging modalities.

Choose Autoplaque if…

Choose Autoplaque if your primary need is AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images to aid in heart attack risk prediction and treatment guidance. This workstation-based software excels at detailed characterization of atherosclerotic plaque, automated vessel and lumen segmentation, and measurement of vessel diameter and area from existing CT data.

View Autoplaque →

Choose V7 Diagnostic Ultrasound System if…

Choose the Samsung V7 Diagnostic Ultrasound System if you require a versatile, high-performance ultrasound scanner with AI-powered tools for a broad range of applications, including women's health, general imaging, and cardiovascular assessments. This on-premise hardware system offers advanced features like automated fetal biometry, semi-automated fetal heart evaluation, and quantitative assessment of tissue stiffness, making it suitable for real-time diagnostic imaging across multiple specialties.

View V7 Diagnostic Ultrasound System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Autoplaque	V7 Diagnostic Ultrasound System
Pricing	Not disclosed	Contact for pricing
Deployment	Workstation-based software, runs on Windows or Mac computer platforms	On-premise (hardware)
FDA Status	1 AI-estimated	1 AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

V7 Diagnostic Ultrasound System

The Samsung V7 Diagnostic Ultrasound System emphasizes an 'efficient workflow re-designed for simplicity' and a 'user-friendly interface' to enhance the daily ultrasound examination experience. Autoplaque is workstation-based software, and while it allows clinician review and editing, there is less explicit information about its overall user experience or workflow efficiency.

Clinical Value

V7 Diagnostic Ultrasound System

The Samsung V7 offers a broader range of AI-powered tools for diagnostic precision across women's health, general imaging, and cardiovascular applications, including automated measurements for fetal biometry, uterine size, and tissue stiffness. Autoplaque focuses specifically on quantitative analysis of coronary plaques and luminal stenoses from CT angiography, aiding in heart attack risk prediction. While both offer significant clinical value in their respective domains, the V7's wider application base gives it an edge in overall clinical utility.

Pricing & Value

Tie

Neither Autoplaque nor the Samsung V7 Diagnostic Ultrasound System publicly disclose their pricing. Autoplaque states 'not disclosed,' and the V7 requires contacting for pricing. Without transparent pricing information for either tool, it is impossible to determine which offers better value.

Enterprise Readiness

V7 Diagnostic Ultrasound System

The Samsung V7 is an on-premise hardware system, indicating a complete, integrated solution for clinical environments, and explicitly states HIPAA compliance. Autoplaque is workstation-based software with no explicit mention of HIPAA compliance or a Business Associate Agreement (BAA) in the provided information, which are crucial for enterprise deployment in healthcare.

Innovation

V7 Diagnostic Ultrasound System

The Samsung V7 Diagnostic Ultrasound System incorporates 'Crystal Architecture' for enhanced imaging and a wide array of 'AI-Powered Intelligent Assist features' for various applications, including automated measurements and advanced flow visualization. Autoplaque utilizes AI for quantitative analysis of coronary plaques and stenosis, which is innovative in its specific domain, but the V7 demonstrates innovation across a broader spectrum of imaging and diagnostic capabilities.

Support & Docs

Tie

The provided information does not offer specific details regarding the level of customer support or documentation available for either Autoplaque or the Samsung V7 Diagnostic Ultrasound System. Therefore, it is not possible to pick a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Autoplaque	V7 Diagnostic Ultrasound System
Name	Autoplaque	V7 Diagnostic Ultrasound System
Company	Cedars-Sinai Medical Center: AIM	Samsung Medison Co.
Description	Autoplaque, developed by Cedars-Sinai AIM, is an FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance.	The Samsung V7 Diagnostic Ultrasound System is a high-performance, versatile ultrasound scanner featuring AI-powered tools and advanced imaging technology for superior diagnostic capabilities across women's health, general imaging, and cardiovascular applications.
Categories	Cardiology AI, Radiology & Imaging AI	Cardiology AI, OB/GYN AI, Radiology & Imaging AI
Specialties	Cardiology, Radiology	Cardiology, Obstetrics & Gynecology, Radiology
Key Features (Examples)	AI-powered quantitative analysis of atherosclerotic plaque, Detection and characterization of coronary artery plaque, Measurement of luminal stenoses	Crystal Architectureu2122 for enhanced 2D, 3D, and color imaging, AI-Powered Intelligent Assist features for diagnostic precision and workflow efficiency, BiometryAssistu2122 for automated fetal biometry measurements

Videos

Demos, reviews, and walkthroughs featuring Autoplaque and V7 Diagnostic Ultrasound System.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems?

Autoplaque is a workstation-based post-processing application designed for cardiologists and radiologists to view and analyze cardiac CT data. It provides automated vessel, plaque, and lumen segmentation that clinicians can review and edit. The V7 Diagnostic Ultrasound System, on the other hand, is an on-premise hardware system with a re-engineered workflow to enhance efficiency, featuring tools like EzExam+u2122 and EzCompareu2122 to minimize steps and keystrokes during ultrasound examinations.

What is the accuracy and sensitivity of each tool for its respective diagnostic purpose?

Autoplaque has shown excellent correlation with intravascular ultrasound (IVUS) for quantifying noncalcified plaque volumes (r = 0.94, P < .001), and was significantly faster than manual analysis. The V7 Ultrasound System utilizes Crystal Architectureu2122 for enhanced 2D, 3D, and color imaging, and includes AI-powered features like 5D Heart Coloru2122 which aims to increase sensitivity and specificity for congenital heart disease screening.

What is the typical learning curve for physicians and sonographers to become proficient with each system?

Autoplaque is intended for use by appropriately trained medical practitioners, suggesting a learning curve associated with its specialized cardiac CT analysis. The V7 Diagnostic Ultrasound System is designed with an intuitive and ergonomic interface, including a customizable touchscreen and streamlined user interface, which suggests an effort to minimize the learning curve for users.

What kind of customer support and training are available for these tools?

While specific details on Autoplaque's customer support are not provided, it is developed by Cedars-Sinai AIM, an academic medical center. For the V7 Diagnostic Ultrasound System, training is typically included with the system, and companies offering the V7 emphasize robust technical support.

What are the audit-trail features of each tool, particularly for reviewing AI-driven analyses?

Autoplaque provides automated vessel, plaque, and lumen segmentation that is reviewable and editable by the clinician, implying a level of auditability for the AI's initial analysis. The V7 Ultrasound System's AI-powered features, such as BiometryAssistu2122 and UterineAssistu2122, are semi-automated, suggesting that clinician oversight and potential for manual adjustment are part of the workflow, which would inherently create an audit trail through user interaction.

How do these tools support multi-site rollouts and data consistency across different locations?

Autoplaque is workstation-based software, running on Windows or Mac platforms, which could allow for consistent deployment across multiple sites if the necessary hardware and software configurations are replicated. The V7 Diagnostic Ultrasound System is an on-premise hardware system, and its consistent imaging quality through Crystal Architectureu2122 and standardized AI-driven tools like EzExam+u2122 and EzCompareu2122 could contribute to data consistency in multi-site rollouts.

What clinical context or specific patient populations would most benefit from each tool?

Autoplaque is specifically designed for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance for patients with suspected coronary artery disease. The V7 Diagnostic Ultrasound System is a versatile system with AI-powered tools for women's health (e.g., fetal biometry, uterine measurements), general imaging, and cardiovascular applications, making it beneficial for a broader range of patients and diagnostic needs.